Latest edition of the Journal of Neuromuscular Diseases now online – Sep 2020
A new issue of the Journal of Neuromuscular Diseases has recently been released. Read it below:
Journal of Neuromuscular Diseases: Volume 7, issue 4
*NMD4C lead investigator Hanns Lochmüller is joint editor-in-chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National Institute of Neurological Disorders and Stroke.
Articles in this issue:
- Towards central nervous system involvement in adults with hereditary myopathies
- Induction of skeletal muscle progenitors and stem cells from human induced pluripotent stem cells
- Lower extremity muscle involvement in the intermediate and Bethlem myopathy forms of COL6-related dystrophy and Duchenne muscular dystrophy: A cross-sectional study
- Ganglionopathies associated with MERRF syndrome: An original report
- Respiratory dysfunction in Becker muscular dystrophy patients: A case series and autopsy report
- Decision-making and selection bias in four observational studies on Duchenne and Becker muscular dystrophy
- Phenotypic spectrum of myopathies with recessive anoctamin-5 mutations
- Natural history of type 1 spinal muscular atrophy in a series of Argentinian children
- Neuroanatomical models of muscle strength and relationship to ambulatory function in spinal muscular atrophy
- Facilitators and barriers to wearing hand orthoses by adults with Duchenne muscular dystrophy: A mixed methods study design
- Identification and characterization of splicing defects by single-molecule real-time sequencing technology (PacBio)
- Swallowing, chewing, and speaking: Frequently impaired in oculopharyngeal muscular dystrophy
- Correlation between quantitative MRI and muscle histopathology in muscle biopsies from healthy controls and patients with IBM, FSHD, and OPMD
- A new point mutation in the PMP22 gene in a family suffering from atypical HNPP
- Severe inflammatory myopathy in a pulmonary carcinoma patient treated with Pembrolizumab: An alert for myologists
- Familial oculo-leptomeningeal transthyretin amyloidosis caused by Leu55Arg mutation
- Taking a Strohl through history: Putting Strohl back in Guillain-Barré-Strohl syndrome
- Measuring outcomes in adults with spinal muscular atrophy: Challenges and future directions – Meeting report
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.